These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7532909)

  • 1. Biologic characterization of hereditary non-polyposis colorectal cancer. Nuclear ploidy, AgNOR count, microvessel distribution, oncogene expression, and grade-related parameters.
    Losi L; Fante R; Di Gregorio C; Aisoni ML; Lanza G; Maestri I; Roncucci L; Pedroni M; Ponz de Leon M
    Am J Clin Pathol; 1995 Mar; 103(3):265-70. PubMed ID: 7532909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis.
    Young J; Simms LA; Biden KG; Wynter C; Whitehall V; Karamatic R; George J; Goldblatt J; Walpole I; Robin SA; Borten MM; Stitz R; Searle J; McKeone D; Fraser L; Purdie DR; Podger K; Price R; Buttenshaw R; Walsh MD; Barker M; Leggett BA; Jass JR
    Am J Pathol; 2001 Dec; 159(6):2107-16. PubMed ID: 11733361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HNPCC and sporadic MSI-H colorectal cancer: a review of the morphological similarities and differences.
    Jass JR
    Fam Cancer; 2004; 3(2):93-100. PubMed ID: 15340259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More differences between HNPCC-related and sporadic carcinomas from the endometrium as compared to the colon.
    van den Bos M; van den Hoven M; Jongejan E; van der Leij F; Michels M; Schakenraad S; Aben K; Hoogerbrugge N; Ligtenberg M; van Krieken JH
    Am J Surg Pathol; 2004 Jun; 28(6):706-11. PubMed ID: 15166662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter hypermethylation frequency and BRAF mutations distinguish hereditary non-polyposis colon cancer from sporadic MSI-H colon cancer.
    McGivern A; Wynter CV; Whitehall VL; Kambara T; Spring KJ; Walsh MD; Barker MA; Arnold S; Simms LA; Leggett BA; Young J; Jass JR
    Fam Cancer; 2004; 3(2):101-7. PubMed ID: 15340260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival of patients with Stage III colon cancer is improved in hereditary non-polyposis colorectal cancer compared with sporadic cases. A Danish registry based study.
    Brixen LM; Bernstein IT; Bülow S; Ehrnrooth E
    Colorectal Dis; 2013 Jul; 15(7):816-23. PubMed ID: 23350633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended microsatellite analysis in microsatellite stable, MSH2 and MLH1 mutation-negative HNPCC patients: genetic reclassification and correlation with clinical features.
    Schiemann U; Müller-Koch Y; Gross M; Daum J; Lohse P; Baretton G; Muders M; Mussack T; Kopp R; Holinski-Feder E
    Digestion; 2004; 69(3):166-76. PubMed ID: 15118395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of extra-colonic tumors in hereditary nonpolyposis colorectal cancer (HNPCC) and familial colorectal cancer (FCC) Brazilian families: An analysis by a Brazilian Hereditary Colorectal Cancer Institutional Registry.
    Oliveira Ferreira F; Napoli Ferreira CC; Rossi BM; Toshihiko Nakagawa W; Aguilar S; Monteiro Santos EM; Vierira Costa ML; Lopes A
    Fam Cancer; 2004; 3(1):41-7. PubMed ID: 15131405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. K-ras and p53 mutations in hereditary non-polyposis colorectal cancers.
    Losi L; Ponz de Leon M; Jiricny J; Di Gregorio C; Benatti P; Percesepe A; Fante R; Roncucci L; Pedroni M; Benhattar J
    Int J Cancer; 1997 Feb; 74(1):94-6. PubMed ID: 9036876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative serum levels of the carcinoembryonic antigen in hereditary non-polyposis colorectal cancer compared to levels in sporadic colorectal cancer.
    Schiemann U; Günther S; Gross M; Henke G; Müller-Koch Y; König A; Muders M; Folwaczny C; Mussack T; Holinski-Feder E
    Cancer Detect Prev; 2005; 29(4):356-60. PubMed ID: 16122885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival of patients with hereditary colorectal cancer: comparison of HNPCC and colorectal cancer in FAP patients with sporadic colorectal cancer.
    Bertario L; Russo A; Sala P; Eboli M; Radice P; Presciuttini S; Andreola S; Rodriguez-Bigas MA; Pizzetti P; Spinelli P
    Int J Cancer; 1999 Jan; 80(2):183-7. PubMed ID: 9935197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of survival between patients with hereditary non polyposis colorectal cancer (HNPCC) and sporadic colorectal cancer.
    Haghighi MM; Vahedi M; Mohebbi SR; Pourhoseingholi MA; Fatemi SR; Zali MR
    Asian Pac J Cancer Prev; 2009; 10(2):209-12. PubMed ID: 19537885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of DNA ploidy pattern and nucleolar organizer regions (AgNOR) in colorectal carcinoma.
    Eminović-Behrem S; Trobonjaca Z; Petrovecki M; Dobi-Babić R; Dujmović M; Jonjić N
    Croat Med J; 2000 Jun; 41(2):154-8. PubMed ID: 10853043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear DNA content and nucleolar organizer regions in colorectal cancer.
    Adachi Y; Kido A; Mori M; Matsushima T; Shimono R; Inoue T; Sugimachi K
    J Surg Oncol; 1995 Jul; 59(3):177-80. PubMed ID: 7609524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of colonic and endometrial carcinomas in Portuguese families with hereditary nonpolyposis colorectal carcinoma significantly increases the probability of detecting a pathogenic mutation in mismatch repair genes, primarily the MSH2 gene.
    Lage PA; Albuquerque C; Sousa RG; Cravo ML; Salazar M; Francisco I; Maia L; Claro I; Suspiro A; Rodrigues P; Raposo H; Fidalgo PA; Nobre-Leitão C
    Cancer; 2004 Jul; 101(1):172-7. PubMed ID: 15222003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenoma prevalence and cancer risk in familial non-polyposis colorectal cancer.
    Lindgren G; Liljegren A; Jaramillo E; Rubio C; Lindblom A
    Gut; 2002 Feb; 50(2):228-34. PubMed ID: 11788565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumoral expression of nuclear cofactor FHL2 is associated with lymphatic metastasis in sporadic but not in HNPCC-associated colorectal cancer.
    Al-Nomani L; Friedrichs J; Schüle R; Büttner R; Friedrichs N
    Pathol Res Pract; 2015 Feb; 211(2):171-4. PubMed ID: 25554651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency and clinical features of multiple tumors of the large bowel in the general population and in patients with hereditary colorectal carcinoma.
    Fante R; Roncucci L; Di GregorioC ; Tamassia MG; Losi L; Benatti P; Pedroni M; Percesepe A; De Pietri S; Ponz de Leon M
    Cancer; 1996 May; 77(10):2013-21. PubMed ID: 8640664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stromal expression of invasion-promoting, matrix-degrading proteases MMP-1 and -9 and the Ets 1 transcription factor in HNPCC carcinomas and sporadic colorectal cancers.
    Behrens P; Mathiak M; Mangold E; Kirdorf S; Wellmann A; Fogt F; Rothe M; Florin A; Wernert N
    Int J Cancer; 2003 Nov; 107(2):183-8. PubMed ID: 12949792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diploid predominance in hereditary nonpolyposis colorectal carcinoma evaluated by flow cytometry.
    Kouri M; Laasonen A; Mecklin JP; Järvinen H; Franssila K; Pyrhönen S
    Cancer; 1990 Apr; 65(8):1825-9. PubMed ID: 2317760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.